Codon

NOVEMBER 3, 2024

Physicians working in the early 20th century had little choice but to treat the world’s most rampant infectious disease with methods such as these. But even now, more than a century later, TB remains the deadliest infectious disease on Earth, killing about 1.2 million people every year. Subscribe to Asimov Press.

Vaccine 83

Vaccine Trials Therapies Treatment 83

The Pharma Data

AUGUST 11, 2020

.–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -577 trial evaluating Opdivo (nivolumab) as an adjuvant therapy for patients with resected esophageal or gastroesophageal junction (GEJ) cancer met its primary endpoint of disease-free survival (DFS) at a pre-specified interim analysis.

Therapies 52

Therapies Trials Disease Treatment 52

The Pharma Data

DECEMBER 29, 2020

As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes. The primary clinical objective of this initial analysis was to determine if there was sufficient efficacy in these patients to warrant continuing the trial (i.e., futility analysis).

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

JANUARY 24, 2021

With a presidential inauguration and a federal holiday, it wasn’t an enormously busy week for clinical trial news, but there was a fair amount, nonetheless. It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. Read on to see. COVID-19-Related. Non-COVID-19-Related.

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

The Pharma Data

NOVEMBER 19, 2020

A study out of Rutgers University found that healthcare staffers, especially nurses, have a higher prevalence of COVID-19 than non-healthcare workers. Centers for Disease Control and Prevention (CDC), there were more than 216,000 confirmed COVID-19 cases in healthcare workers in the U.S., As of November 15, 2020, according to the U.S.

Research 52

Research Nurses Disease Immune Response 52

The Pharma Data

DECEMBER 14, 2020

Centers for Disease Control and Prevention Director Robert R. Recently published CDC guidelines recommend that health care workers and nursing home residents and staff should be the first to receive the vaccine. Redfield, M.D., signed the recommendation by the Advisory Committee on Immunization Practices on Saturday night.

Vaccine 52

Vaccine Nurses FDA Virus 52

The Pharma Data

OCTOBER 25, 2020

The Company plans to initiate a Phase 2 trial within the next several months. “We An exploratory endpoint of this trial will be to determine the overall clinical improvement after drug administration using the Clinical Global Impression – Improvement Scale (“CGI-I”).

Treatment 52

Treatment Trials FDA Hospitals 52

The Pharma Data

AUGUST 11, 2020

The safety profiles of Opdivo and chemotherapy in this trial are reflective of the known safety profiles of Opdivo and chemotherapy in first-line gastric and esophageal cancers. The company remains blinded to data from this arm and the trial continues in follow-up to allow the data to mature. PRINCETON, N.J.–( Janjigian, M.D.,

Treatment 52

Treatment Trials Therapies Clinical Trials 52

The Pharma Data

APRIL 28, 2023

This milestone is a testament to advancing our robust biopharmaceutical pipeline of innovative medicines that aim to support more people living with mental health disorders and neurological diseases in the coming years.” Each relapse carries a biological risk of loss of function, treatment refractoriness, and changes in brain morphology.

FDA Approval 40

FDA Approval Treatment FDA Clinical Trials 40

The Pharma Data

JANUARY 27, 2021

The report entitled “Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women” was written by nurse practitioner Melissa Fesler and internist Raphael Stricker from the Alan E. Union Square Medical Associates is an internal medicine practice that specializes in the treatment of tick-borne diseases. # # #. Source link.

Vaccine 52

Vaccine Nurses International Treatment 52

Olympian Clinical Research

JUNE 25, 2020

million Americans suffering from Alzheimer’s dementia, a degenerative brain disease that slowly destroys a person’s memory and impairs their speech, thinking, and behavior. Changes in living situation, such as moving to a new residence home or nursing home. What Is Alzheimer’s Dementia Agitation ? There are currently over 5.8

Nurses 78

Nurses Clinical Research Clinical Trials Hospitals 78

The Pharma Data

DECEMBER 10, 2020

She’s an associate dean of research at Indiana University School of Nursing, in Indianapolis. The purpose of Carpenter’s study was to investigate menopausal palpitation distress in women by analyzing data from clinical trials on menopausal health. We do often work these women up for heart disease because of these symptoms.

Doctors 52

Doctors Nurses Therapies Clinical Trials 52

The Pharma Data

JULY 23, 2021

. “Serious infections in children can be difficult to treat and the impact of ABSSSI among children is significant, as these infections often require IV antibiotics, resulting in hospitalization,” said Margaret Burroughs, medical director, infectious diseases, AbbVie. Use in Specific Populations.

FDA Approval 52

FDA Approval FDA Clinical Trials Trials 52

The Pharma Data

MARCH 25, 2021

Real-world evidence is woven into the fabric of how we innovate and advance care for patients with breast cancer, supporting our randomized clinical trials,” said Chris Boshoff, M.D., This real-world cohort includes more than 1,400 women with HR+, HER2- mBC with any extent of visceral disease. 2,3 In the U.S., The full U.S.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

DECEMBER 3, 2020

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e.,

Treatment 52

Treatment Pharmaceutical Companies Therapies Virus 52

The Pharma Data

NOVEMBER 20, 2020

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as casirivimab and imdevimab have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

DECEMBER 4, 2020

As for Fauci, Biden made it clear that the nation’s top infectious diseases expert would be a central player in the U.S. Around the world, researchers are testing 57 vaccines in clinical trials, and nearly 100 others are being tested in animals or cell, the Times reported. Just 100 days to mask — not forever, just 100 days.

Vaccine 52

Vaccine Long-Term Care Facilities Nurses Hospitals 52

The Pharma Data

DECEMBER 3, 2020

Centers for Disease Control and Prevention warned Wednesday that the coming winter months might be the darkest period yet in the coronavirus pandemic. Around the world, researchers are testing 57 vaccines in clinical trials, and nearly 100 others are being tested in animals or cell, the Times reported. THURSDAY, Dec. A global scourge.

Hospitals 52

Hospitals Vaccine Long-Term Care Facilities Nurses 52

The Pharma Data

DECEMBER 17, 2020

NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. TARRYTOWN, N.Y. , 17, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc.

Hospitals 52

Hospitals Production Clinical Trials Therapies 52

The Pharma Data

DECEMBER 14, 2020

ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Both vaccines have demonstrated about 94-95% efficacy in clinical trials. To date, the research into the vaccines indicates it prevents symptomatic COVID-19 and appears to prevent severe disease.

Vaccine 52

Vaccine FDA Virus Government 52

The Pharma Data

NOVEMBER 24, 2020

Centers for Disease Control and Prevention stressed that Americans who get a shot shouldn’t be surprised if they feel under the weather for a few days afterwards. She represents the National Association of Pediatric Nurse Practitioners, and said providers must be ready to explain this to people who line up to get any COVID-19 vaccine.

Vaccine 52

Vaccine Immune Response Virus Hospitals 52

The Pharma Data

JANUARY 12, 2021

“Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D. .” Have chronic kidney disease. Have diabetes.

Government 52

Government Hospitals Virus Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

The retrospective study shows that prespecified triggers of aHUS were reported in approximately one-third of patients with aHUS, and that long-term clinical disease manifestations persisted in the majority of patients with aHUS who were not treated with SOLIRIS ® (eculizumab). In addition, an observational analysis of U.S. About ULTOMIRIS ®.

Doctors 52

Doctors Vaccine Nurses Treatment 52

The Pharma Data

NOVEMBER 21, 2020

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load. Data from these trials will be used to support a future BLA submission.

FDA 40

FDA Clinical Trials Hospitals Production 40

The Pharma Data

APRIL 28, 2021

The opinion is based on results from the double-blind, placebo-controlled VIALE-A (M15-656) and the Phase 1b open-label, nonrandomized, multicenter M14-358 trial. 1 An estimated 160,000 people are currently living with the disease globally. 1 An estimated 160,000 people are currently living with the disease globally.

Clinical Trials 40

Clinical Trials Trials Therapies Treatment 40

The Pharma Data

NOVEMBER 18, 2020

. “Effective delivery of this treatment can be logistically complicated,” said Dr. Kami Kim , director of the Division Infectious Diseases and International Medicine at USF Health Morsani College of Medicine. Have chronic kidney disease. Have diabetes.

Hospitals 40

Hospitals Treatment Virus Nurses 40

The Pharma Data

JANUARY 11, 2021

million, will boost its vaccine rollout to now include health care workers, nursing home residents and staff, as well as those living in congregate settings such as assisted living or shelters. Centers for Disease Control and Prevention agreed. Health officials had hoped to get 20 million people vaccinated by Jan.

Vaccine 52

Vaccine Virus Assisted Living Nurses 52

The Pharma Data

JANUARY 26, 2021

“Notably, the 70 percent decrease in risk of hospitalizations or death seen in this Phase 3 trial of bamlanivimab and etesevimab together is consistent with the reduction in risk of hospitalization or ER visits seen with bamlanivimab alone in the Phase 2 trial. INDIANAPOLIS, Jan. Across 1,035 patients, there were 11 events (2.1

Hospitals 52

Hospitals Treatment Trials Long-Term Care Facilities 52

The Pharma Data

FEBRUARY 8, 2021

IBRANCE is indicated for the treatment of adult patients with HR+, HER2- advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or in men; or with fulvestrant in patients with disease progression following endocrine therapy. 2,3 In the U.S., The full U.S.

Clinical Trials 52

Clinical Trials Treatment Therapies Production 52

The Pharma Data

DECEMBER 11, 2020

Health care workers and nursing home residents and staff should get the first shots, according to guidelines issued recently by the U.S. Centers for Disease Control and Prevention. Instead, a modified version of the vaccine will be tested in a smaller trial set to begin in February, the newspaper said. Who is first in line?

Vaccine 52

Vaccine FDA Hospitals Doctors 52

The Pharma Data

DECEMBER 1, 2020

13 to 17 and attracted participants from around the world, including cardiovascular specialists, surgeons, and nurses as well as other health care professionals. The researchers found that increased greenness and air quality reduced cardiovascular disease mortality. In a cross-sectional study, William Aitken, M.D., born Black women.

Hospitals 52

Hospitals Disease Treatment Therapies 52

The Pharma Data

DECEMBER 2, 2020

Still, the temperature requirement could dictate who will be vaccinated first in Britain: While nursing home residents were supposed to be the top priority under an advisory committee’s plans, efforts to limit transportation of the vaccine may mean that National Health Service staff will receive the shots first, the Times reported.

Vaccine 40

Vaccine Long-Term Care Facilities Hospitals Nurses 40

Altus Drug Development

MAY 31, 2022

The treatment of chronic diseases like diabetes, obesity, high blood pressure, and cancer is both emotionally taxing and extremely expensive. Developing novel methodologies can help nurses and other people in charge of delivering care to better handle the treatment of patients.

Pharmaceuticals 52

Pharmaceuticals Treatment Packaging Doctors 52

The Pharma Data

JUNE 18, 2021

“The CLL14 trial results observed after four years of follow-up with treatment of venetoclax plus obinutuzumab show that these patients can experience long-lasting responses without disease progression, years after stopping treatment,” said Mohamed Zaki , M.D., NORTH CHICAGO, Ill. months; hazard ratio [HR] 0.33 [95% CI 0.25-0.45]);

Treatment 40

Treatment Trials Therapies Clinical Trials 40

The Pharma Data

MAY 14, 2021

Because after many years of personal trials and experiments, I believe that I have finally discovered a special blend of ingredients which may help anyone support healthy prostate. Products are not intended to diagnose, treat, cure or prevent any disease. Trust me, this is the last thing you’d want to do!

Packaging 52

Packaging Synthetic Chemistry Production Nurses 52

The Pharma Data

JUNE 18, 2021

This most recent approval is based on results from the Phase 3 double-blind, placebo-controlled VIALE-A (M15-656) and the Phase 1b open-label, nonrandomized, multicenter M14-358 clinical trials. 4 An estimated 160,000 people are currently living with the disease globally. and by AbbVie outside of the U.S. .

Clinical Trials 40

Clinical Trials Treatment Trials Therapies 40

The Pharma Data

JUNE 18, 2021

The study met its primary endpoint of superior progression-free survival (PFS) as assessed by an independent review committee (IRC) with a HR 0.216 (95% CI, 0.131-0.357; p < 0.0001), demonstrating a reduction in the risk of disease progression or death for I+V of approximately 78% compared to C+O. . About the GLOW Study.

Treatment 52

Treatment Therapies FDA FDA Approval 52